Cytokeratins 20 and 7 as biomarkers
Top Cited Papers
- 1 January 2002
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 38 (6) , 758-763
- https://doi.org/10.1016/s0959-8049(02)00008-4
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Systematic reviews in health care: Systematic reviews of evaluations of prognostic variablesBMJ, 2001
- Coordinate Expression of Cytokeratins 7 and 20 in Prostate Adenocarcinoma and Bladder Urothelial CarcinomaAmerican Journal of Clinical Pathology, 2000
- A comparative evaluation of immunohistochemical markers for the differential diagnosis of malignant pleural tumoursHistopathology, 1998
- Adenocarcinoma in Females Detected in Serous EffusionsActa Cytologica, 1997
- Immunohistochemical differentiation of metastatic breast carcinomas from metastatic adenocarcinomas of other common primary sitesHistopathology, 1996
- Utility of cytokeratin 20 in identifying the origin of metastatic carcinomas in effusionsDiagnostic Cytopathology, 1995
- Cytokeratin intermediate filament expression in benign and malignant breast disease.Journal of Clinical Pathology, 1995
- OV‐TL 12/30 (keratin 7 antibody) is a marker of glandular differentiation in lung cancerHistopathology, 1993
- Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin‐embedded human tissuesThe Journal of Pathology, 1991
- Keratin expression in the normal breast and in breast carcinomaHistopathology, 1991